Press release from Companies

Publicerat: 2025-05-15 10:01:00

PolarCool AB: PolarCool Signs an Agreement with Premier League Club Southampton FC

The Med-Tech company PolarCool AB (publ.) announces a three-year partnership with English Premier League club Southampton FC. The club will integrate PolarCap® into its senior team’s matchday and training protocols to support the management of concussion and optimize player welfare.

The club’s medical and performance teams will utilize the treatment with PolarCap® on players suffering concussions, aiming to reduce the exercised induced elevated brain temperature, shown to mitigate the effects of concussions and improve recovery (link).

Elite Football is becoming an increasingly important target market for PolarCool. Head injuries and concussions pose a significant challenge within the sport, for both players and clubs as they cause physical suffering, absence, and substantial costs when they occur. As a result, PolarCool is experiencing growing interest from several top European clubs, as well as recently signing 1. FC Köln in German Football.

Erik Andersson, PolarCool CEO comments:

-We are proud that Southampton FC now will include treatment with PolarCap® in their concussion management routines. The clubs commitment to player safety and innovation aligns perfectly with our mission to change the way head injuries are treated in professional sport. This partnership further strengthens PolarCap®:s position as a trusted solution for clubs at the absolute highest level in football.

Southampton FC is an elite English club known for its strong focus on youth development and holistic athlete care. The club joins a growing number of organizations across football, rugby, and ice hockey that are prioritizing player brain health through science-backed solutions.

The multi-year partnership will also include potential collaborative research opportunities, performance insights, and joint initiatives aimed at raising awareness around concussion protocols in football and the importance of early intervention.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail:
erik.andersson@polarcool.se

About PolarCool AB (publ.)

PolarCool AB (publ.) is a Swedish medical technology company focused on developing and marketing products in the sports medicine field. Its primary product, PolarCap®, is designed to reduce the impact of concussion through targeted brain cooling. PolarCool works with professional teams across Europe in rugby, football, and ice hockey and it shares are listed on Spotlight Stock Market

Läs mer hos Cision
Läs mer om PolarCool AB